| Design and synthesis of novel 1, 2, 3-triazole linked hybrids: Molecular docking, MD simulation, and their antidiabetic efficacy as α-Amylase inhibitors AR Zala, HN Naik, I Ahmad, H Patel, S Jauhari, P Kumari Journal of Molecular Structure 1285, 135493, 2023 | 24 | 2023 |
| Dalbergia sissoo phytochemicals as EGFR inhibitors: an in vitro and in silico approach HN Naik, D Kanjariya, S Parveen, A Meena, I Ahmad, H Patel, R Meena, ... Journal of Biomolecular Structure and Dynamics 42 (10), 5415-5427, 2024 | 9 | 2024 |
| Environmentally benign plant-based polymeric organogel for wastewater treatment HN Naik, D Kanjariya, N Malek, R Meena, S Jauhari Journal of Molecular Liquids 387, 122659, 2023 | 9 | 2023 |
| LC–MS profiling, in vitro and in silico C-ABL kinase inhibitory approach to identify potential anticancer agents from Dalbergia sissoo leaves HN Naik, D Kanjariya, S Parveen, I Ahmed, A Meena, H Patel, R Meena, ... Scientific Reports 14 (1), 73, 2024 | 8 | 2024 |
| Design and synthesis of pyrrolo[2,3-d]pyrimidine linked hybrids as α-amylase inhibitors: molecular docking, MD simulation, ADMET and antidiabetic screening AR Zala, R Tiwari, HN Naik, I Ahmad, H Patel, S Jauhari, P Kumari Molecular Diversity 28 (3), 1681-1695, 2024 | 6 | 2024 |
| α-Amylase and mycobacterium-TB H37Rv antagonistic efficacy of novel pyrazole-coumarin hybrids: an in vitro and in silico investigation DC Kanjariya, HN Naik, MJ Sherashiya, YT Naliapara, I Ahmad, H Patel, ... Journal of Biomolecular Structure and Dynamics 42 (23), 12788-12805, 2024 | 5 | 2024 |
| Design, Synthesis, and Evaluation of Quinoline‐1,2,3‐Triazole Hybrids as CYP51 Inhibitors: In Silico Study and In Vitro Antimicrobial Assessment BK Chabhadiya, HN Naik, BA Mohite, I Ahmad, Y Naliapara, D Rajani, ... ChemistrySelect 9 (36), e202402221, 2024 | 1 | 2024 |
| Synthesis of cefixime loaded PCL/HPMC blend nanoparticles: a controlled release study and in vitro anti-bacterial evaluation Y Naik, HN Naik, J Rai, R Shah, S Jauhari, AJ Patel Journal of Microencapsulation 41 (8), 844-855, 2024 | | 2024 |
